Suitability of the PAXgene™ system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia
-
Thomas Ernst
Abstract
Background: Optimum sample quality is a crucial requirement for molecular monitoring of patients with chronic myeloid leukemia (CML) on therapy. Bedside RNA stabilization systems (e.g., PAXgene™) have been developed to inhibit RNA degradation during shipment of samples from the clinical site to the specialized laboratory. In CML, blood but not bone marrow samples have been examined using RNA stabilization in previous studies. Therefore, we sought to investigate the applicability of the PAXgene™ system for bone marrow samples in CML.
Methods: Simultaneously stabilized blood and bone marrow samples were obtained from 55 imatinib-resistant CML patients to compare RNA yield and purity, expression of two housekeeping genes (total ABL and β-glucuronidase; GUS) by quantitative reverse-transcriptase polymerase chain reaction, BCR-ABL expression (ratios BCR-ABL/ABL and BCR-ABL/GUS), and BCR-ABL kinase domain mutations analyzed by denaturing high-performance liquid chromatography and direct sequencing.
Results: RNA extraction revealed high-quality RNA derived from both stabilized blood and bone marrow samples. RNA yield was significantly higher in bone marrow (median 9.9 μg RNA/mL bone marrow) than in blood (median 4.3 μg RNA/mL blood) (p=0.0005). The number of housekeeping gene transcripts was comparable in blood and bone marrow (median ABL copies/2 μL cDNA 13,260 vs. 25,590; median GUS copies/2 μL cDNA 35,490 vs. 60,200; n.s.). Further, ratios BCR-ABL/ABL (blood vs. bone marrow, median 47% vs. 57%) and ratios BCR-ABL/GUS (blood vs. bone marrow, median 26% vs. 21%) were not significantly different. Results of mutation analysis corresponded in 51 out of 55 patients (93%), whereas moderate differences were observed in four patients.
Conclusions: We conclude that bone marrow can be effectively stabilized using the PAXgene™ system and shows concordance with blood in terms of BCR-ABL mRNA quantification and mutation analysis in imatinib-resistant CML patients.
Clin Chem Lab Med 2008;46:318–22.
©2008 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Genetics and Molecular Diagnostics
- A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry
- An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls
- Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy
- Suitability of the PAXgene™ system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia
- Genetic polymorphisms of alcohol metabolising enzymes: their role in susceptibility to oesophageal cancer
- 5′ ins/del and 3′ VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease
- General Clinical Chemistry and Laboratory Medicine
- Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties
- Simple method for determining human serum 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity – possible application in clinical studies on dietary antioxidants
- Thyroid-related autoantibodies in Tunisian patients with coeliac disease
- A dried serum spot assay for vitamin B12
- Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers
- Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients
- Effects of total cholesterol and triglyceride on the percentage difference between the low-density lipoprotein cholesterol concentration measured directly and calculated using the Friedewald formula
- Gallstone analysis using Fourier transform infrared spectroscopy (FT-IR)
- Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy
- Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease
- Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension
- Reference Values
- Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients
- Infrequency of low red blood cell (RBC) folate levels despite no folate fortification program: a study based on results from routine requests for RBC folate
- Validation and Outcome Studies
- A new serum cystatin C-based equation for assessing glomerular filtration rate in liver transplantation
- Development of des-γ-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer
- Letters to the Editor
- High oxygen-affinity hemoglobin variant associated with high-level venous oxygen saturation
- Interference in urinary free cortisol determination by components of the NuvaRing® contraceptive device
- The neutral protease chymase degrades apolipoprotein E from high-density lipoproteins
- Unclear results in the article by Wolff and Gerritzen in Clin Chem Lab Med 2007;45(7):917–922
- Potassium report of hemolyzed serum samples
- Reply to the letter by Carraro: appropriate actions in the detection of haemolytic specimens
Articles in the same Issue
- Genetics and Molecular Diagnostics
- A rapid and accurate approach to identify single nucleotide polymorphisms of mitochondrial DNA using MALDI-TOF mass spectrometry
- An association study of sodium-lithium countertransport activity with glutathione S transferase (GST) T1 and GST M1 null polymorphisms in Greek dyslipidaemic patients and controls
- Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy
- Suitability of the PAXgene™ system to stabilize bone marrow RNA in imatinib-resistant patients with chronic myeloid leukemia
- Genetic polymorphisms of alcohol metabolising enzymes: their role in susceptibility to oesophageal cancer
- 5′ ins/del and 3′ VNTR polymorphisms in the apolipoprotein B gene in relation to lipids and coronary artery disease
- General Clinical Chemistry and Laboratory Medicine
- Isolation and biochemical characterization of plasma monoclonal free light chains in amyloidosis and multiple myeloma: a pilot study of intact and truncated forms of light chains and their charge properties
- Simple method for determining human serum 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity – possible application in clinical studies on dietary antioxidants
- Thyroid-related autoantibodies in Tunisian patients with coeliac disease
- A dried serum spot assay for vitamin B12
- Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers
- Vitamin D binding protein, a new nutritional marker in cystic fibrosis patients
- Effects of total cholesterol and triglyceride on the percentage difference between the low-density lipoprotein cholesterol concentration measured directly and calculated using the Friedewald formula
- Gallstone analysis using Fourier transform infrared spectroscopy (FT-IR)
- Coenzyme Q10 and high-sensitivity C-reactive protein in ischemic and idiopathic dilated cardiomyopathy
- Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease
- Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension
- Reference Values
- Lithium heparinised blood-collection tubes give falsely low albumin results with an automated bromcresol green method in haemodialysis patients
- Infrequency of low red blood cell (RBC) folate levels despite no folate fortification program: a study based on results from routine requests for RBC folate
- Validation and Outcome Studies
- A new serum cystatin C-based equation for assessing glomerular filtration rate in liver transplantation
- Development of des-γ-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer
- Letters to the Editor
- High oxygen-affinity hemoglobin variant associated with high-level venous oxygen saturation
- Interference in urinary free cortisol determination by components of the NuvaRing® contraceptive device
- The neutral protease chymase degrades apolipoprotein E from high-density lipoproteins
- Unclear results in the article by Wolff and Gerritzen in Clin Chem Lab Med 2007;45(7):917–922
- Potassium report of hemolyzed serum samples
- Reply to the letter by Carraro: appropriate actions in the detection of haemolytic specimens
